Cancer screening test use - United States, 2013.

Susan A. Sabatino, Mary C. White, Trevor Thompson, Carrie N. Klabunde

PubMed · 2015 · 201 citations · 11 references

Concepts

TL;DR

Regular breast, cervical, and colorectal cancer screening with timely follow‑up reduces deaths, and Healthy People 2020 targets are set according to USPSTF guidelines. CDC used 2013 National Health Interview Survey data to monitor progress toward those targets for breast, cervical, and colorectal cancer screening. Overall screening use remained below targets with no improvement from 2010 to 2013, cervical screening declined, and disparities persist, indicating that increased efforts are needed.

Abstract

Regular breast, cervical, and colorectal cancer (CRC) screening with timely and appropriate follow-up and treatment reduces deaths from these cancers. Healthy People 2020 targets for cancer screening test use have been established, based on the most recent U.S. Preventive Services Task Force (USPSTF) guidelines. National Health Interview Survey (NHIS) data are used to monitor progress toward the targets. CDC used the 2013 NHIS, the most recent data available, to examine breast, cervical, and CRC screening use. Although some demographic subgroups attained targets, screening use overall was below the targets with no improvements from 2010 to 2013 in breast, cervical, or CRC screening use. Cervical cancer screening declined from 2010 to 2013. Increased efforts are needed to achieve targets and reduce screening disparities.

References

11